q2 adjusted earnings per share $1.05.
qtrly revenue decreased 1 percent to $37.9 million, or $6.5 million.
qtrly scientific revenue increased 16% year-on-year.
qtrly organic revenue decreased 4.3 percent.
q2 revenue rose 31.2 percent to $60.1 million.
qtrly specialty solutions revenue decreased 17.8% to $22.8 million.
expect capital expenditures for fiscal 2021 to be between $25 million and $28 million.
qtrly engineering technologies revenue decreased 33.9% to $17.5 million and operating income decreased 60.2%.